These data showed that BCL2, BCL2L1 (BCL-XL coding gene), MCL1, and BCL2A1 (BFL-1 coding gene) are abundantly expressed in most SCLC patients’ tumors (Fig. 1a). This evidence concerns the gene BCL2L1 and small cell lung carcinoma.